Our Team
Andy McElroy
Andy McElroy, Acting CEO, has 40 years experience in the pharmaceutical industry. For many years he was a medicinal chemist and project manager at Pfizer with leadership roles in the pain therapeutic area. He oversaw collaborative work to progress a range of therapeutic projects within TRN and continues to play a role to ensure the effective transfer of the Pol III project to Betathera.
Prof. Danielle Skropeta
Danielle Skropeta is a Professor of Medicinal Chemistry at the University of Wollongong (UOW), Associate Dean of Higher Degree Research at UOW and a Fellow and Board member of the Royal Australian Chemical Institute (RACI). She leads an interdisciplinary research group focussed on drug development in cancer, wound healing and bacterial infection, working in collaboration with industry partners to translate discoveries into therapeutic products to benefit society. Dr Skropeta obtained her Ph.D. at the Australian National University in Canberra (Australia) in 2000. She has authored over 70 publications in peer-reviewed journals. Dr Skropeta also has extensive project management experience including multimillion dollar budgets and in 2020 was the recipient of the national RACI Margaret Sheil award for her work promoting gender equity in the chemical sciences.
Dr Haibo Yu
Dr Haibo Yu is a computational chemist who joined the School of Chemistry and Molecular Bioscience at the University of Wollongong in 2010. He completed his undergraduate study at the University of Science and Technology of China under the supervision of Professor Yunyu Shi and his Ph.D. at the ETH Zürich under the supervision of Professor Wilfred F. van Gunsteren. He then conducted postdoctoral training at the University of Wisconsin-Madison with Professor Qiang Cui and the University of Chicago with Professor Benoît Roux.
Professor Nick Dixon
Professor Nick Dixon holds a Ph.D. in Biochemistry from the University of Queensland (1978). He was awarded C.J. Martin and Fulbright Fellowships to study with Nobel laureate Prof Arthur Kornberg at Stanford University where he was introduced to the field of bacterial DNA replication. He returned to Australia as a Queen Elizabeth II Fellow at the Australian National University in 1983, and took up his present position as Professor of Biological Chemistry at the University of Wollongong in 2006. He was awarded an Australian Research Council Australian Professorial Fellowship and established UOWs Centre for Medical and Molecular Bioscience in 2010. He is currently an academic leader of Molecular Horizons, an advancedfacility for molecular visualization that opened in 2020.
A/Professor Aaron Oakley
Structural biology is the study of the molecular structure of biological macromolecules, their formation, and the structural basis of their function. Dr Oakley has been active in structural biology and computational biology for over 25 years, and moved to the University of Wollongong as an Australian Research Council Future Fellow in 2010. One of his major research interests is the discovery of inhibitors of DNA replication and their development as potential antibiotics.